HB 1214: Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit. Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supply of diabetes equipment and supplies.

Sponsors

Sponsors by party (alphabetical): Democratic 6

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. April 13, 2026Approved by Governor-Chapter 752 (effective 7/1/2026)
2. April 13, 2026Fiscal Impact Statement from State Corporation Commission (HB1214)
3. March 31, 2026Governor's Action Deadline 11:59 p.m., April 13, 2026
4. March 31, 2026Enrolled Bill communicated to Governor on March 31, 2026
5. March 31, 2026Signed by Speaker
6. March 30, 2026Signed by President
7. March 30, 2026Bill text as passed House and Senate (HB1214ER)
8. March 30, 2026Enrolled
9. March 12, 2026Senate amendment agreed to by House (97-Y 0-N 0-A)
10. March 11, 2026Passed Senate with amendment Block Vote (40-Y 0-N 0-A)
11. March 11, 2026Reconsideration of Senate passage agreed to by Senate Block Vote (40-Y 0-N 0-A)
12. March 11, 2026Passed Senate with amendment Block Vote (39-Y 0-N 0-A)

Showing 12 most recent of 33 actions. Full history